Kronox Lab Sciences IPO
Kronox Lab Sciences is gearing up for its IPO, a book-built issue worth ₹130.15 crores. If you’re considering investing in this IPO, here’s everything you need to know, including the IPO date, price, GMP, review, and more.
IPO Overview
Kronox Lab Sciences is launching an IPO entirely as an offer for sale, with a total of 0.96 crore shares up for grabs. The subscription window opens on June 3, 2024, and closes on June 5, 2024. Post allotment, the shares are expected to list on BSE and NSE by June 10, 2024.
Key Details
Details | Information |
---|---|
IPO Date | June 3, 2024 to June 5, 2024 |
Listing Date | June 10, 2024 |
Face Value | ₹10 per share |
Price Band | ₹129 to ₹136 per share |
Lot Size | 110 Shares |
Total Issue Size | 9,570,000 shares (₹130.15 Cr) |
Offer for Sale | 9,570,000 shares (₹130.15 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Pre-issue Shareholding | 37,104,000 shares |
Post-issue Shareholding | 37,104,000 shares |
IPO Reservation
Investor Category | Shares Offered |
---|---|
QIB (Qualified Institutional Buyers) | Not more than 50% of the Net Issue |
Retail Investors | Not less than 35% of the Net Issue |
NII (Non-Institutional Investors) | Not less than 15% of the Net Issue |
IPO Timeline
The tentative schedule for Kronox Lab Sciences IPO is as follows:
Event | Date |
---|---|
IPO Open Date | June 3, 2024 |
IPO Close Date | June 5, 2024 |
Basis of Allotment | June 6, 2024 |
Initiation of Refunds | June 7, 2024 |
Credit of Shares to Demat | June 7, 2024 |
Listing Date | June 10, 2024 |
UPI Mandate Confirmation | 5 PM on June 5, 2024 |
Investment Details
Minimum and Maximum Investment
Investors can apply for shares in lots, with each lot comprising 110 shares. Here’s a breakdown of the investment required for different investor categories:
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 110 | ₹14,960 |
Retail (Max) | 13 | 1430 | ₹194,480 |
sNII (Min) | 14 | 1,540 | ₹209,440 |
sNII (Max) | 66 | 7,260 | ₹987,360 |
bNII (Min) | 67 | 7,370 | ₹1,002,320 |
About Kronox Lab Sciences
Kronox Lab Sciences Limited, established in 2008, is a leading manufacturer of high-purity specialty fine chemicals. These chemicals cater to diverse industries such as pharmaceuticals, nutraceuticals, biotech, agrochemicals, and more.
The company boasts a wide product range of over 185 items, including phosphates, sulphates, chlorides, and more. Kronox Lab Sciences exports its products to over 20 countries, including the USA, UK, China, and Australia.
Manufacturing Facilities
Kronox Lab Sciences has three manufacturing units in Vadodara, Gujarat, covering an area of 17,454 sq. m. These facilities have a combined installed capacity of 7,242 TPA and hold various certifications like ISO 9001:2015, ISO 14001:2015, and FSSC 22000.
Financial Performance
The company has shown consistent growth over the years. Here’s a snapshot of its financials:
Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
---|---|---|---|---|
Assets (₹ Cr) | 66.96 | 54.03 | 56.79 | 37.65 |
Revenue (₹ Cr) | 68.44 | 97.50 | 83.34 | 63.24 |
PAT (₹ Cr) | 15.47 | 16.62 | 13.63 | 9.73 |
Net Worth (₹ Cr) | 60.28 | 44.68 | 40.35 | 26.81 |
Reserves (₹ Cr) | 15.56 | 7.58 | 40.11 | 26.57 |
Key Performance Indicators
KPI | Values |
---|---|
ROE | 25.66% |
ROCE | 33.15% |
RoNW | 25.66% |
P/BV | 8.37 |
PAT Margin (%) | 22.6 |
Promoters
The company is promoted by Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani, holding a pre-issue stake of 99.98%.
IPO Objectives
The primary objectives of the IPO are:
- Offer for Sale: Up to 95,70,000 Equity Shares by the Promoter Selling Shareholders.
- Listing Benefits: Enhance the company’s visibility, brand image, and provide liquidity to existing shareholders.
Review and Recommendation
The IPO has received positive feedback, particularly due to the company’s strong position in the high-purity specialty chemical segment. Given the consistent financial growth and robust market presence, investors might find this IPO an attractive opportunity for medium to long-term rewards.
FAQs about Kronox Lab Sciences IPO
The IPO price band is set between ₹129 to ₹136 per share.
The IPO is expected to list on BSE and NSE on June 10, 2024.
A total of 9,570,000 shares are offered, aggregating up to ₹130.15 crores.
Retail investors need to invest a minimum of ₹14,960 for 110 shares.
Pantomath Capital Advisors Pvt Ltd is the book-running lead manager for this IPO.